PDK4 and colorectal cancer: It was later published that miR-23a promotes colorectal cancer cell survival by targeting PDK4 [28], and recently, the participation of miR-23a∼27a∼24 clusters in CRC progression via reprogramming metabolism to switch from oxidative phosphorylation to glycolysis in a hypoxic tumor environment was reported [29].